Your browser doesn't support javascript.
loading
Combined metabolic activators therapy ameliorates liver fat in nonalcoholic fatty liver disease patients.
Zeybel, Mujdat; Altay, Ozlem; Arif, Muhammad; Li, Xiangyu; Yang, Hong; Fredolini, Claudia; Akyildiz, Murat; Saglam, Burcin; Gonenli, Mehmet Gokhan; Ural, Dilek; Kim, Woonghee; Schwenk, Jochen M; Zhang, Cheng; Shoaie, Saeed; Nielsen, Jens; Uhlén, Mathias; Borén, Jan; Mardinoglu, Adil.
Afiliação
  • Zeybel M; NIHR Nottingham Biomedical Research Centre, Nottingham University Hospitals NHS Trust & University of Nottingham, Nottingham, UK.
  • Altay O; Nottingham Digestive Diseases Centre, School of Medicine, University of Nottingham, Nottingham, UK.
  • Arif M; Department of Gastroenterology and Hepatology, School of Medicine, Koç University, Istanbul, Turkey.
  • Li X; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
  • Yang H; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
  • Fredolini C; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
  • Akyildiz M; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
  • Saglam B; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
  • Gonenli MG; Department of Gastroenterology and Hepatology, School of Medicine, Koç University, Istanbul, Turkey.
  • Ural D; Department of Gastroenterology and Hepatology, School of Medicine, Koç University, Istanbul, Turkey.
  • Kim W; Department of Gastroenterology and Hepatology, School of Medicine, Koç University, Istanbul, Turkey.
  • Schwenk JM; Department of Cardiology, School of Medicine, Koç University, Istanbul, Turkey.
  • Zhang C; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
  • Shoaie S; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
  • Nielsen J; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
  • Uhlén M; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, China.
  • Borén J; Science for Life Laboratory, KTH - Royal Institute of Technology, Stockholm, Sweden.
  • Mardinoglu A; Centre for Host-Microbiome Interactions, Faculty of Dentistry, Oral & Craniofacial Sciences, King's College London, London, UK.
Mol Syst Biol ; 17(10): e10459, 2021 10.
Article em En | MEDLINE | ID: mdl-34694070
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hepatopatia Gordurosa não Alcoólica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article